This renewal application seeks continuing support for the "Microenvironmental Influences in Cancer" Training Program (MICTP) at Vanderbilt University. Over the past 24 years and continuing with the 5-year period preceding this competitive renewal, we have been remarkably successful in recruiting and training excellent students and postdoctoral fellows, particularly those from groups underrepresented in science. Overall, the MIC training program encompasses a group of 26 faculty members from both the Vanderbilt University School of Medicine and the Meharry Medical College. The training program is conducted within a vibrant academic environment and is supported by close interactions with the Vanderbilt-lngram Comprehensive Cancer Center, the Vanderbilt Department of Cancer Biology, and the Vanderbilt-Meharry Alliance Program. In addition to departmental and preceptor-specific laboratory instruction, each trainee receives cancer-related training in the form of two courses focused on cancer biology, a grant workshop, an annual Tumor-Host Interaction Program retreat, and a "Clinical Experience". Trainees within the program are actively mentored by both faculty members and through "paired peer mentoring" by former student and postdoctoral trainees. Furthermore, predoctoral students are supported by an Interdisciplinary Graduate Program and an independent graduate program in Cancer Biology. Postdoctoral trainees are supported by an institutional Office of Postdoctoral Affairs, which provides both financial and academic support as well as career development advice and opportunities. Significant institutional investment in training programs, core facilities, state-of the-art laboratories and equipment further enhances trainee development. Training in this critical area of cancer research is necessary to build the workforce required to understand the complexities of the microenvironmental influence on cancer development and progression, and to translate this information into more effective and less toxic approaches to the treatment and prevention of cancer. Furthermore, training in tumor microenvironment will prepare our students and postdoctoral fellows to solve the major unsolved or neglected problems, "the provocative questions", in oncology.

Public Health Relevance

One of the rapidly developing frontiers in cancer research is the tumor microenvironment. Training in this critical area of cancer research is necessary to build the workforce required to understand the complexities of the microenvironmental influence on cancer development and progression, and to translate this information into more effective and less toxic approaches to the treatment and prevention of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
3T32CA009592-27S1
Application #
8840343
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ogunbiyi, Peter
Project Start
1997-08-15
Project End
2018-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
27
Fiscal Year
2014
Total Cost
$29,456
Indirect Cost
$2,134
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Scott, Sarah A; Spencer, Cierra T; O'Reilly, Matthew C et al. (2015) Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes. ACS Chem Biol 10:421-32
Krakowiak, M S; Noto, J M; Piazuelo, M B et al. (2015) Matrix metalloproteinase 7 restrains Helicobacter pylori-induced gastric inflammation and premalignant lesions in the stomach by altering macrophage polarization. Oncogene 34:1865-71
Chen, Jin; Song, Wenqiang; Amato, Katherine (2015) Eph receptor tyrosine kinases in cancer stem cells. Cytokine Growth Factor Rev 26:6-Jan
Andl, Thomas; Le Bras, Grégoire F; Richards, Nicole F et al. (2014) Concerted loss of TGF?-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma. Carcinogenesis 35:2602-10
Skrypnyk, Nataliya; Chen, Xiwu; Hu, Wen et al. (2014) PPAR* activation can help prevent and treat non-small cell lung cancer. Cancer Res 74:621-31
Andrews, Omozusi E; Cha, Diana J; Wei, Chunyao et al. (2014) RNAi-mediated gene silencing in zebrafish triggered by convergent transcription. Sci Rep 4:5222
Palmer, Trenis D; Martinez, Carlos H; Vasquez, Catalina et al. (2014) Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression. Cancer Res 74:173-87
Lindsey Jr, R Hunter; Pendleton, MaryJean; Ashley, Rachel E et al. (2014) Catalytic core of human topoisomerase II?: insights into enzyme-DNA interactions and drug mechanism. Biochemistry 53:6595-602
DeGraff, David J; Grabowska, Magdalena M; Case, Tom C et al. (2014) FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype. Lab Invest 94:726-39
Cleveland, Susan M; Goodings, Charnise; Tripathi, Rati M et al. (2014) LMO2 induces T-cell leukemia with epigenetic deregulation of CD4. Exp Hematol 42:581-93.e5

Showing the most recent 10 out of 153 publications